News
We bring you up to date at all times: Discover the latest industry news from biotechnology, pharmaceuticals and life sciences. Researched by us so you don't have to.
Selected departments
Selected industries
Companies
The Who's Who of Life Sciences: Discover companies from all over the world. Here you can easily find the provider matching your search, including contact options.
Selected countries
Selected companies
Products
The first stop for your procurement process: discover innovative products for lab and process that make your everyday life easier and solve even complex challenges.
Products of selected companies
White papers
What could be better than an application problem that has already been solved by others? Tap into in-depth application knowledge from proven experts. Conveniently via download to your device.
Most read white papers
White papers of selected companies
Webinars
Exciting lectures and practical application tips via video, whenever you want: Our on-demand webinars make it possible. Make yourself comfortable and click play.
Selected webinars
Webinars of selected companies
Knowledge & education
Question. Answer. Find articles on 57,945 keywords in life science, biotech, pharma, biology and related science disciplines in the encyclopedia..
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
Note
The function "Store search" is only available to registered users.
Important information
Currently, you are not logged in to my.bionity.com. Therefore, you can remember a maximum of 5 contents.
FILTER
Refine your search with the following facets to narrow down your results.
21-Dec-2012 - Biotron Limited (BIT) has completed the clinical stage of a landmark phase 1b/2a proof-of-concept human trial of its lead HIV drug candidate, BIT225. The placebo-controlled, double-blinded study was undertaken at a clinical trial unit in Bangkok, Thailand. Patients enrolled in the trial were ...
12-Oct-2011 - Biotron Limited has headline results from its Phase 2a trial of its lead drug candidate, BIT225 in Hepatitis C virus (HCV) infected patients. Preliminary analysis of trial data confirms that BIT225, an orally administered, small molecule drug, has good antiviral activity against HCV. Patients ...
14-Mar-2011 - Biotron Limited has completed stage one of a human trial of its lead Hepatitis C drug candidate, BIT225. Twelve patients have been dosed in the first half of the trial being undertaken by ACLIRES, an international contract research organisation (CRO) that specialises in running antiviral drug ...
18-Dec-2009 - Biotron Limited announced that anti-viral drug BIT225 is able to stop HIV spreading. The drug was tested in a study involving 18 HIV positive patients at Sydney’s St Vincent’s Hospital. Scientists at the Fourth International Workshop on HIV Persistence During Therapy heard the drug was able to ...
© 1997-2024 LUMITOS AG, All rights reserved